Literature DB >> 2666327

Human urinary kallikrein. Complete amino acid sequence and sites of glycosylation.

H S Lu1, F K Lin, L Chao, J Chao.   

Abstract

Human glandular kallikrein was purified from urine and subjected to detailed structural characterization. The protein was carboxymethylated with iodoacetic acid and digested with TPCK-trypsin, Staphylococcal aureus V-8 protease and endo LysC peptidase. The resulting peptide fragments were separated by reverse-phase HPLC using C-4 columns and acetonitrile-trifluoroacetic acid gradient elution. The complete amino acid sequence of the carboxymethylated derivative was elucidated by sequence analysis and alignment of peptides derived from different proteolytic cleavages. A procedure using in situ CNBr cleavage of a large endo LysC peptidase-derived peptide followed by direct sequencing was carried out to provide overlap for two glycosylation sites at residues 78 and 84. Three Asn-linked glycosylation sites were confirmed by the direct sequence analysis of the isolated glycopeptides. However, the third glycosylation at Asn-144 occurs only in 60% of kallikrein molecules. Reverse-phase HPLC effectively separates two species of HUK which correspond to molecules glycosylated and non-glycosylated at Asn-144, respectively. The human urinary kallikrein contains 238 amino acid residues with Ile and Ser as N- and C-terminal amino acids, respectively. The primary structure is completely identical to that deduced from a human genomic DNA sequence (F.K. Lin et al., manuscript in preparation) and is different in one amino acid (Lys-162 vs. Glu-162) from that deduced from pancreatic or kidney cDNA sequence.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2666327     DOI: 10.1111/j.1399-3011.1989.tb01277.x

Source DB:  PubMed          Journal:  Int J Pept Protein Res        ISSN: 0367-8377


  6 in total

1.  Kallistatin is a potent new vasodilator.

Authors:  J Chao; J N Stallone; Y M Liang; L M Chen; D Z Wang; L Chao
Journal:  J Clin Invest       Date:  1997-07-01       Impact factor: 14.808

2.  Cloning and characterization of a Pseudomonas mendocina KR1 gene cluster encoding toluene-4-monooxygenase.

Authors:  K M Yen; M R Karl; L M Blatt; M J Simon; R B Winter; P R Fausset; H S Lu; A A Harcourt; K K Chen
Journal:  J Bacteriol       Date:  1991-09       Impact factor: 3.490

3.  Differential interactions of human kallikrein-binding protein and alpha 1-antitrypsin with human tissue kallikrein.

Authors:  L M Chen; L Chao; R K Mayfield; J Chao
Journal:  Biochem J       Date:  1990-04-01       Impact factor: 3.857

4.  A novel protease homolog differentially expressed in breast and ovarian cancer.

Authors:  A Anisowicz; G Sotiropoulou; G Stenman; S C Mok; R Sager
Journal:  Mol Med       Date:  1996-09       Impact factor: 6.354

5.  Expression and characterization of rat kallikrein-binding protein in Escherichia coli.

Authors:  J X Ma; L Chao; G Zhou; J Chao
Journal:  Biochem J       Date:  1993-06-15       Impact factor: 3.857

6.  Molecular cloning, purification and in situ localization of human colon kallikrein.

Authors:  L M Chen; G P Richards; L Chao; J Chao
Journal:  Biochem J       Date:  1995-04-15       Impact factor: 3.857

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.